HESTER BIOSCIENCES LTD.
BSE: 524669
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 72.66-22.5% | 93.71+33.2% | 70.35+8.9% | 64.58+1.7% | 63.49-17.2% | 76.67+22.0% | 62.83-14.5% | 73.50 |
| Other Income | 1.68-59.7% | 4.18+303.8% | 1.03-29.8% | 1.48+55.9% | 0.95-10.6% | 1.06-18.8% | 1.30-3.2% | 1.35 |
| Total Income | 74.34-24.1% | 97.89+37.1% | 71.39+8.1% | 66.05+2.5% | 64.44-17.1% | 77.73+21.2% | 64.13-14.3% | 74.85 |
| EXPENSES | ||||||||
| Expenditure | 54.59-22.0% | 70.02+23.4% | 56.75+1.0% | 56.17+3.7% | 54.15-18.3% | 66.25+14.9% | 57.64-7.6% | 62.37 |
| Tax | 5.04-40.6% | 8.49+113.6% | 3.97+48.6% | 2.67+9.1% | 2.45+32.6% | 1.85-9.9% | 2.05-34.8% | 3.15 |
| PROFIT | ||||||||
| PBT | 19.75-43.4% | 34.87+138.2% | 14.64+48.2% | 9.88-3.9% | 10.29-10.4% | 11.48+76.9% | 6.49-48.0% | 12.48 |
| Net Profit | 14.71-44.2% | 26.38+147.3% | 10.67+48.0% | 7.21-8.0% | 7.84-18.7% | 9.63+117.1% | 4.44-52.5% | 9.34 |
| KEY METRICS | ||||||||
| OPM % | 33.51%-7.53pp | 41.04%+17.28pp | 23.76%+5.36pp | 18.40%-1.15pp | 19.55%+1.68pp | 17.87%+15.70pp | 2.17%-8.09pp | 10.26% |
| NPM % | 19.79%-7.16pp | 26.95%+12.01pp | 14.94%+4.03pp | 10.91%-1.25pp | 12.16%-0.24pp | 12.40%+5.48pp | 6.92%-5.55pp | 12.47% |
| EPS | 17.29-44.2% | 31.01+147.3% | 12.54+47.9% | 8.48-7.9% | 9.21-18.7% | 11.33+117.0% | 5.22-52.4% | 10.97 |
Corporate Events
Board MeetingHESTERBIO
202630Jul
Board Meeting
The Board of Directors have approved the unaudited Standalon…
BSE Filing ↗ Board MeetingHESTERBIO
202621Jul
Board Meeting
The 39th Annual General Meeting of Hester Biosciences Limite…
BSE Filing ↗ Board MeetingHESTERBIO
202428Oct
Board Meeting
Consider and approve the unaudited standalone and consolidat…
BSE Filing ↗ Board MeetingHESTERBIO
20242Aug
Board Meeting
Consider and approve the unaudited standalone financial resu…
BSE Filing ↗ Board MeetingHESTERBIO
202410May
Board Meeting
consider and approve audited standalone and consolidated fin…
BSE Filing ↗ Board MeetingHESTERBIO
20242Feb
Board Meeting
Consideration and approval of standalone and consolidated un…
BSE Filing ↗ Board MeetingHESTERBIO
20237Nov
Board Meeting
Consider and approve the standalone and consolidated unaudit…
BSE Filing ↗ Board MeetingHESTERBIO
20238Aug
Board Meeting
consider and approve the standalone and consolidated unaudit…
BSE Filing ↗